Skip to main content

Advertisement

SpringerLink
Log in

Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Background experimental studies have shown that taurolidine suppresses intraperitoneal tumor growth following local application in rats. In opposite, a single intravenous therapy affected neither intraperitoneal nor subcutaneous growth of malignancies. Thus, an intravenous long-term therapy with taurolidine was investigated in rats after administration of a subcutaneous tumor load. VEGF and TNFα production and their effects on tumor growth have not been elucidated so far. Methods VEGF and TNFα levels of rat colon adenocarcinoma cells (DHD/K12/TRb) were analyzed in the supernatant undergoing treatment of increasing taurolidine doses in vitro. Besides the cell experiments rats were treated intravenously. At the beginning of the operation, 10 000 colon adenocarcinoma cells were applied subcutaneously at the back of the rats. Then the animals (n = 80, BD IX rats) were randomized into eight groups and underwent a standardized midline laparotomy for 30 min. At the end of the operation the animals were given either a bolus (1 ml Ringer’s solution) or a long-term intravenous therapy (7 days, eight-hourly 1 ml 1%, 2%, or 3% taurolidine) were performed. For long-term therapy, a jugularis vein port catheter system was placed and left for 1 week. The influence on subcutaneous tumor growth, animal growth, general side effects and leukocyte/granulocyte levels were analyzed. Total tumor weights were determined 4 weeks after cell application. Results The VEGF and TNFα levels decreased rapidly after taurolidine therapy with low doses in vitro. The subcutaneous tumor growth showed a downtrend of tumor weight (P = 0.075) with a statistical significance in solid tumor counts (P = 0.04) at the back of the animals. A slight and temporary depression in animal growth was observed only in long-term therapy groups. Independent of the therapeutic agents and the application forms, the operation itself caused a slight leukopenia shortly after the operation compensated by a moderate leukocytosis in the following course. Fast injections of taurolidine led to a reduction of breathing rate. Conclusions Only the intravenous long-term therapy of 3% taurolidine led to a slight downregulation in subcutaneous tumor growth. The changes of leukocyte counts were not affected by taurolidine. Fast injections have to be avoided. The findings prompted us to start new experiments to determine the influence of increasing doses of taurolidine on progressive tumor growth in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

TNFα:

tumor necrosis factor alpha

VEGF:

vascular endothelial growth factor

References

  1. CA Jacobi FJ Peter FA Wenger et al. (1999) ArticleTitleNew therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: Results of a tumor model in the rat Dig Surg 16 393–9 Occurrence Handle10.1159/000018754 Occurrence Handle10567800

    Article  PubMed  Google Scholar 

  2. M McCourt JH Wang S Sookhai HP. Redmond (2000) ArticleTitleTaurolidine inhibits tumor cell growth in vitro and in vivo Ann Surg Oncol 7 685–91 Occurrence Handle10.1007/s10434-000-0685-6 Occurrence Handle11034247

    Article  PubMed  Google Scholar 

  3. C Braumann J Ordemann P Wildbrett CA. Jacobi (2000) ArticleTitleInfluence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats Clin Exp Metast 18 547–52 Occurrence Handle10.1023/A:1011988923523

    Article  Google Scholar 

  4. C Braumann J Ordemann M Kilian et al. (2003) ArticleTitleLocal and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy Clin Exp Metast 20 387–94 Occurrence Handle10.1023/A:1025402919341

    Article  Google Scholar 

  5. I Bedrosian RD Sofia SM Wolff CA. Dinarello (1991) ArticleTitleTaurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells Cytokine 3 568–75 Occurrence Handle10.1016/1043-4666(91)90483-T Occurrence Handle1790304

    Article  PubMed  Google Scholar 

  6. L Lanfrancone D Boraschi P Ghiara et al. (1992) ArticleTitleHuman peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1 Blood 80 2835–42 Occurrence Handle1280480

    PubMed  Google Scholar 

  7. DJ Van Antwerp SJ Martin IM Verma DR Green (1998) ArticleTitleInhibition of TNF-induced apoptosis by NF-kappa B Trends Cell Biol 8 107–11 Occurrence Handle10.1016/S0962-8924(97)01215-4 Occurrence Handle9695819

    Article  PubMed  Google Scholar 

  8. RW. Pfirrmann (1991) ArticleTitleTaurolin in der Anwendung bei chirurgischen Infektionen Chir Gastrolenterol 131 42

    Google Scholar 

  9. SW Lee RL Whelan JC Southall M. Bessler (1998) ArticleTitleAbdominal wound tumor recurrence after open and laparoscopic-assisted splenectomy in a murine model Dis Colon Rectum 41 824–31 Occurrence Handle9678366

    PubMed  Google Scholar 

  10. T Iwanaka G Arya MM. Ziegler (1998) ArticleTitleMechanism and prevention of port-site tumor recurrence after laparoscopy in a murine model J Pediatr Surg 33 457–61 Occurrence Handle10.1016/S0022-3468(98)90088-4 Occurrence Handle9537557

    Article  PubMed  Google Scholar 

  11. SJ Neuhaus DI Watson T Ellis et al. (1999) ArticleTitleInfluence of cytotoxic agents on intraperitoneal tumor implantation after laparoscopy Dis Colon Rectum 42 10–5 Occurrence Handle10211514

    PubMed  Google Scholar 

  12. SJ Neuhaus DI Watson T Ellis et al. (1998) ArticleTitleEfficacy of cytotoxic agents for the prevention of laparoscopic port-site metastases Arch Surg 133 762–6 Occurrence Handle10.1001/archsurg.133.7.762 Occurrence Handle9688006

    Article  PubMed  Google Scholar 

  13. M Stuntz G Wilmoth J Ong et al. (1997) ArticleTitleUse of intraperitoneal 5-fluorouracil and chlorhexidine for prevention of recurrence of perforated colorectal carcinoma in a rat model Dis Colon Rectum 40 1085–8 Occurrence Handle10.1007/BF02050934 Occurrence Handle9293940

    Article  PubMed  Google Scholar 

  14. JS Wu SM Pfister MB Ruiz et al. (1998) ArticleTitleLocal treatment of abdominal wound reduces tumor implantation J Surg Oncol 69 9–13 Occurrence Handle10.1002/(SICI)1096-9098(199809)69:1<9::AID-JSO3>3.0.CO;2-7 Occurrence Handle9762885

    Article  PubMed  Google Scholar 

  15. H Torisu M Ono H Kiryu et al. (2000) ArticleTitleMacrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFalpha and IL-1alpha Int J Cancer 85 182–8 Occurrence Handle10.1002/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M Occurrence Handle10629075

    Article  PubMed  Google Scholar 

  16. Pfirrmann RW. Einführung und Übersicht. In Brückner WL, Pfirrmann RW (eds): Taurolin – ein neues Konzept zur antimikrobiellen Chemotherapie chirurgischer Infektionen. Munich: Urban & Schwarzenberg 1985.

  17. CA Jacobi P Wildbrett T Volk JM. Mueller (1999) ArticleTitleInfluence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model Surg Endosc 13 1021–5 Occurrence Handle10.1007/s004649901160 Occurrence Handle10526040

    Article  PubMed  Google Scholar 

  18. P Calabresi FA Goulette JW. Darnowski (2001) ArticleTitleTaurolidine: Cytotoxic and mechanistic evaluation of a novel antineoplastic agent Cancer Res 61 6816–21 Occurrence Handle11559556

    PubMed  Google Scholar 

  19. M Yanagisawa H Imai Y Fukushima et al. (1994) ArticleTitleEffects of tumour necrosis factor alpha and interleukin 1 beta on the proliferation of cultured glomerular epithelial cells Virch Arch 424 581–6 Occurrence Handle10.1007/BF01069736

    Article  Google Scholar 

  20. Z Han I Ribbizi P Pantazis et al. (2002) ArticleTitleThe antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism Anticancer Res 22 1959–64 Occurrence Handle12174870

    PubMed  Google Scholar 

  21. R Stendel G Stoltenburg-Didinger CL Al Keikh et al. (2002) ArticleTitleThe effect of taurolidine on brain tumor cells Anticancer Res 22 809–14 Occurrence Handle12014655

    PubMed  Google Scholar 

  22. DP Shrayer H Lukoff T King P Calabresi (2003) ArticleTitle The effect of taurolidine on adherent and floating subpopulations of melanoma cells Anticancer Drugs 14 295–303 Occurrence Handle10.1097/00001813-200304000-00007 Occurrence Handle12679734

    Article  PubMed  Google Scholar 

  23. Knight (1981) ArticleTitlePeritoneal absorption of the antibacterial and antiendotoxin taurolin in peritonitis Br J Clin Pharmacol 12 695–9 Occurrence Handle7332737

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General, Visceral, Vascular and Thoracic Surgery, Medical Faculty Charité, Humboldt University, Schumannstr. 20/21, Berlin, Germany

    Chris Braumann, Marco Schoenbeck, Charalambos Menenakos, Maik Kilian & Christoph A. Jacobi

Authors
  1. Chris Braumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Schoenbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charalambos Menenakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maik Kilian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christoph A. Jacobi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chris Braumann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braumann, C., Schoenbeck, M., Menenakos, C. et al. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats. Clin Exp Metastasis 22, 77–83 (2005). https://doi.org/10.1007/s10585-005-4695-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-005-4695-4

Keywords

Search

Navigation